Glucosamine derivative modified nanostructured lipid carriers for targeted tumor delivery

Journal of Materials Chemistry

Volumn 22, Issue 12, 2012, Pages 5770-5783

  Chen, Jing ^a   Chen, Haiyan ^a   Cui, Sisi ^a   Xue, Bing ^a   Tian, Junmei ^a   Achilefu, Samuel ^b   Gu, Yueqing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-TUMORS; ANTICANCER DRUG; DRUG ENTRAPMENT; DYNAMIC BEHAVIORS; FLUORESCENT DYES; GLYCERYL MONOSTEARATE; IN-VITRO; LOW TOXICITY; MODEL DRUGS; NANOSTRUCTURED LIPID CARRIERS; NEAR-INFRARED FLUORESCENCE; PACLITAXEL; STANDARD METHOD; STORAGE STABILITY; TARGETED CHEMOTHERAPY; TARGETED DELIVERY; TUMOR CELLS; TUMOR DIAGNOSIS; TUMOR TARGETING;

CHEMOTHERAPY; DRUG PRODUCTS; FLUORESCENCE; GLUCOSAMINE; INFRARED DEVICES; MAMMALS; OLEIC ACID; PARTICLE SIZE; STEARIC ACID; ZETA POTENTIAL;

TUMORS;

EID: 84863238890     PISSN: 09599428     EISSN: 13645501     Source Type: Journal    
DOI: 10.1039/c2jm15830b     Document Type: Article

References (40)

1. M. Goutayer S. Dufort V. Josserand A. Royere E. Heinrich F. Vinet J. Bibette J.-L. Coll I. Texier Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging Eur. J. Pharm. Biopharm. 2010 75 137 147
2. H. L. Wong A. M. Rauth R. Bendayan X. Y. Wu In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model Eur. J. Pharm. Biopharm. 2007 65 300 308
3. H. L. Wong R. Bendayan A. M. Rauth Y. Li X. Y. Wu Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles Adv. Drug Delivery Rev. 2007 59 491 504
4. S. A. Wissing O. Kayser R. H. Muller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Delivery Rev. 2004 56 1257 1272
5. A. A. Attama B. C. Schicke T. Paepenmuller C. C. Muller-Goymann Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization Eur. J. Pharm. Biopharm. 2007 67 48 57
6. R. H. Muller S. A. Runge V. Ravelli A. F. Thunemann W. Mehnert E. B. Souto Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation Eur. J. Pharm. Biopharm. 2008 68 535 544
7. Y. C. Kuo H. H. Chen Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles Int. J. Pharm. 2009 365 206 213
8. A. del Pozo-Rodriguez S. Pujals D. Delgado M. A. Solinis A. R. Gascon E. Giralt J. L. Pedraz A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors J. Controlled Release 2009 133 52 59
9. V. Teeranachaideekul R. H. Muller V. B. Junyaprasert Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-effects of formulation parameters on physicochemical stability Int. J. Pharm. 2007 340 198 206
10. M. Joshi S. Pathak S. Sharma V. Patravale Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject Int. J. Pharm. 2008 364 119 126
11. F. Q. Hu S. P. Jiang Y. Z. Du H. Yuan Y. Q. Ye S. Zeng Preparation and characteristics of monostearin nanostructured lipid carriers Int. J. Pharm. 2006 314 83 89
12. C. C. Chen T. H. Tsai Z. R. Huang J. Y. Fang Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics Eur. J. Pharm. Biopharm. 2010 74 474 482
13. S. Doktorovova J. Araujo M. L. Garcia E. Rakovsky E. B. Souto Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC) Colloids Surf., B 2010 75 538 542
14. C. H. Liu C. T. Wu Optimization of nanostructured lipid carriers for lutein delivery Colloids Surf., A 2010 353 149 156
15. F. Han S. M. Li R. Yin H. Z. Liu L. Xu Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers Colloids Surf., A 2008 315 210 216
16. M. C. Coleman C. R. Asbury D. Daniels J. Du N. Aykin-Burns B. J. Smith L. Li D. R. Spitz J. J. Cullen 2-DG causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer Free Radical Biol. Med. 2008 44 322 331
17. O. Warburg Origin of cancer cells Science 1956 123 309 314
18. A. V. Korotcov Y. Ye Y. Chen F. Zhang S. Huang S. Lin R. Sridhar S. Achilefu P. C. Wang Glucosamine-linked near-infrared fluorescent probes for imaging of solid tumor xenografts Mol. Imaging Biol. 2011 10.1007/s11307-011- 0520-4
19. R. G. O'Neil L. Wu N. Mullani Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells Mol. Imaging Biol. 2005 7 388 392
20. M. Zhang Z. Zhang D. Blessington H. Li T. M. Busch V. Madrak J. Miles B. Chance J. D. Glickson G. Zheng Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters Bioconjugate Chem. 2003 14 709 714
21. Y. Ye S. Bloch J. Kao S. Achilefu Multivalent carbocyanine molecular probes: synthesis and applications Bioconjugate Chem. 2005 16 51 61
22. H. Yuan J. Miao Y. Z. Du J. You F. Q. Hu S. Zeng Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells Int. J. Pharm. 2008 348 137 145
23. F. Liu D. Deng X. Chen Z. Qian S. Achilefu Y. Gu Folate-polyethylene glycol conjugated near-infrared fluorescence probe with high targeting affinity and sensitivity for in vivo early tumor diagnosis Mol. Imaging Biol. 2010 12 595 607
24. F. Q. Li S. X. Zhang L. X. An Y. Q. Gu In vivo molecular targeting effects of anti-Sp17-ICG-Der-02 on hepatocellular carcinoma evaluated by an optical imaging system J. Exp. Clin. Cancer Res. 2011 30 25
25. L. Larush S. Magdassi Formation of near-infrared fluorescent nanoparticles for medical imaging Nanomedicine 2011 6 233 240
26. S. Achilefu R. B. Dorshow J. E. Bugaj R. Rajagopalan Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging Invest. Radiol. 2000 35 479 485
27. Y. Ye S. Bloch S. Achilefu Polyvalent carbocyanine molecular beacons for molecular recognitions J. Am. Chem. Soc. 2004 126 7740 7741
28. H. J. Yao R. J. Ju X. X. Wang Y. Zhang R. J. Li Y. Yu L. Zhang W.-L. Lu The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery Biomaterials 2011 32 3285 3302
29. X. Li S. F. Nie J. Kong N. Li C. Y. Ju W. S. Pan A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers Int. J. Pharm. 2008 363 177 182
30. X. G. Zhang J. Miao Y. Q. Dai Y. Z. Du H. Yuan F. Q. Hu Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells Int. J. Pharm. 2008 361 239 244
31. L. Jia D. Zhang Z. Li C. Duan Y. Wang F. Feng F. Wang Y. Liu Q. Zhang Nanostructured lipid carriers for parenteral delivery of silybin: biodistribution and pharmacokinetic studies Colloids Surf., B 2010 80 213 218
32. V. Teeranachaideekul P. Boonme E. B. Souto R. H. Muller V. B. Junyaprasert Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC J. Controlled Release 2008 128 134 141
33. X. Y. Zhang J. P. Liu H. Qiao H. Liu J. Ni W. Zhang Y. Shi Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology Powder Technol. 2010 197 120 128
34. State Pharmacopoeia Committee, Chinese Pharmacopoeia (2010) section II, China Medical Science Press, Beijing, 2010
35. Y. Xu X. Jin Q. Ping J. Cheng M. Sun F. Cao W. You D. Yuan A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery J. Controlled Release 2010 146 299 308
36. C.-Y. Zhuang N. Li M. Wang X.-N. Zhang W.-S. Pan J.-J. Peng Y.-S. Pan X. Tang Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability Int. J. Pharm. 2010 394 179 185
37. X. H. Lin X. W. Li L. Q. Zheng L. Yu Q. Q. Zhang W. C. Liu Preparation and characterization of monocaprate nanostructured lipid carriers Colloids Surf., A 2007 311 106 111
38. R. R. Patlolla M. Chougule A. R. Patel T. Jackson P. N. Tata M. Singh Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers J. Controlled Release 2010 144 233 241
39. F. Li Y. Weng L. Wang H. He J. Yang X. Tang The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers Int. J. Pharm. 2010 393 203 211
40. T. Tanaka S. Shiramoto M. Miyashita Y. Fujishima Y. Kaneo Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME) Int. J. Pharm. 2004 277 39 61